Literature DB >> 17006281

Hypothesis: Neonatal respiratory distress may be related to asymptomatic colonization with group B streptococci.

Feng Ying C Lin1, James F Troendle.   

Abstract

BACKGROUND: Phospholipids from the group B streptococcal (GBS) cell wall cause pulmonary hypertension in experimental animals. When exposed to penicillin, Streptococcus mutans releases phospholipids immediately. We hypothesize that newborns colonized with GBS receive bacterial phospholipids leading to pulmonary hypertension and respiratory distress, especially in the situation of newborns of penicillin-treated mothers. We examined clinical and epidemiologic data on these relations.
METHODS: We used data from a prospective multicenter GBS study conducted from 1995 to 1999 in which 1674 of 17,690 newborns cultured at 4 sites were colonized with GBS. Our analyses included 1610 colonized newborns > or =32 weeks gestation without early-onset disease. Clinical features were compared between 1003 lightly colonized (GBS positive at < or =2 sites) and 607 heavily colonized (positive at 3 or 4 sites) newborns. The rates of respiratory distress were compared between colonized newborns of penicillin-treated mothers and those of untreated mothers.
RESULTS: Of the 1610 colonized newborns, 8.8% had signs of respiratory distress within 48 hours after birth (cases). Oxygen supplementation was used in 60% of the cases, mechanical ventilation was required in 5% and persistent pulmonary hypertension was diagnosed in 2%. Compared with light colonization, heavy colonization increased the rate of respiratory distress 1.73-fold (95% CI, 1.26-2.38), a discharge diagnosis of respiratory disorder 2.02-fold (95% CI, 1.16-3.52), a blood/cerebrospinal fluid obtained for culture 1.54-fold (95% CI, 1.24-1.93) and antibiotic administration after birth 1.87-fold (95% CI, 1.34-2.61). Penicillin use during labor was associated with a 2.62-fold (95% CI, 1.79-3.83) increase in respiratory distress in the colonized newborn.
CONCLUSIONS: Our findings support the association of neonatal respiratory distress with asymptomatic GBS colonization and with penicillin use during labor. These data require confirmation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006281     DOI: 10.1097/01.inf.0000239322.58890.94

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

Review 2.  Group B Streptococcus, phospholipids and pulmonary hypertension.

Authors:  J Curtis; G Kim; N B Wehr; R L Levine
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

3.  Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease.

Authors:  Feng-Ying C Lin; Leonard E Weisman; Parvin Azimi; Amy E Young; Kathleen Chang; Mikhaela Cielo; Patricia Moyer; James F Troendle; Rachel Schneerson; John B Robbins
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

Review 4.  Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review.

Authors:  Farah Seedat; Chris Stinton; Jacoby Patterson; Julia Geppert; Bee Tan; Esther R Robinson; Noel Denis McCarthy; Olalekan A Uthman; Karoline Freeman; Samantha Ann Johnson; Hannah Fraser; Colin Stewart Brown; Aileen Clarke; Sian Taylor-Phillips
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-26       Impact factor: 3.007

5.  Vertical transmission of group B Streptococcus and associated factors among pregnant women: a cross-sectional study, Eastern Ethiopia.

Authors:  Tesfaye Assebe Yadeta; Alemayehu Worku; Gudina Egata; Berhanu Seyoum; Dadi Marami; Yemane Berhane
Journal:  Infect Drug Resist       Date:  2018-03-13       Impact factor: 4.003

6.  The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci.

Authors:  Germana Lentini; Angelina Midiri; Arnaud Firon; Roberta Galbo; Giuseppe Mancuso; Carmelo Biondo; Emanuela Mazzon; Annamaria Passantino; Letizia Romeo; Patrick Trieu-Cuot; Giuseppe Teti; Concetta Beninati
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.